Pro-Cure’s existing investors include White Rose Technology Limited, YFM Equity Partners (through its Yorkshire & Humber Equity Fund), Yorkshire Cancer Research and the University of York.

We are always willing to talk to organisations or individuals interested in making an equity investment in the company or in providing alternative forms of funding. For further information, please contact Dr Michael McLean.